156 related articles for article (PubMed ID: 11107113)
21. An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas.
Takeda O; Handa M; Uehara T; Maseki N; Sakashita A; Sakurai M; Kanda N; Arai Y; Kaneko Y
Br J Cancer; 1996 Nov; 74(10):1620-6. PubMed ID: 8932344
[TBL] [Abstract][Full Text] [Related]
22. Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.
Villamón E; Berbegall AP; Piqueras M; Tadeo I; Castel V; Djos A; Martinsson T; Navarro S; Noguera R
PLoS One; 2013; 8(1):e53740. PubMed ID: 23341988
[TBL] [Abstract][Full Text] [Related]
23. Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: a novel diagnostic tool for therapy stratification of neuroblastoma.
Yagyu S; Iehara T; Gotoh T; Miyachi M; Katsumi Y; Kikuchi K; Tsuchiya K; Osone S; Kuroda H; Sugimoto T; Sawada T; Hosoi H
Cancer Lett; 2011 Oct; 309(2):185-9. PubMed ID: 21726937
[TBL] [Abstract][Full Text] [Related]
24. Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?
Stallings RL; Howard J; Dunlop A; Mullarkey M; McDermott M; Breatnach F; O'Meara A
Cancer Genet Cytogenet; 2003 Jan; 140(2):133-7. PubMed ID: 12645651
[TBL] [Abstract][Full Text] [Related]
25. Deletion of chromosome 11 and of 14q sequences in neuroblastoma.
Srivatsan ES; Ying KL; Seeger RC
Genes Chromosomes Cancer; 1993 May; 7(1):32-7. PubMed ID: 7688553
[TBL] [Abstract][Full Text] [Related]
26. Deletion mapping of chromosome 11 in carcinoma of the bladder.
Shaw ME; Knowles MA
Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
[TBL] [Abstract][Full Text] [Related]
27. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
28. Allelotype of neuroblastoma.
Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.
Srivatsan ES; Murali V; Seeger RC
Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183
[TBL] [Abstract][Full Text] [Related]
30. 11q deletion in neuroblastoma: a review of biological and clinical implications.
Mlakar V; Jurkovic Mlakar S; Lopez G; Maris JM; Ansari M; Gumy-Pause F
Mol Cancer; 2017 Jun; 16(1):114. PubMed ID: 28662712
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas.
Fieuw A; Kumps C; Schramm A; Pattyn F; Menten B; Antonacci F; Sudmant P; Schulte JH; Van Roy N; Vergult S; Buckley PG; De Paepe A; Noguera R; Versteeg R; Stallings R; Eggert A; Vandesompele J; De Preter K; Speleman F
Int J Cancer; 2012 Jun; 130(11):2599-606. PubMed ID: 21796619
[TBL] [Abstract][Full Text] [Related]
32. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
[TBL] [Abstract][Full Text] [Related]
34. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma.
Takeda O; Homma C; Maseki N; Sakurai M; Kanda N; Schwab M; Nakamura Y; Kaneko Y
Genes Chromosomes Cancer; 1994 May; 10(1):30-9. PubMed ID: 7519871
[TBL] [Abstract][Full Text] [Related]
35. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis.
Van Gele M; Van Roy N; Jauch A; Laureys G; Benoit Y; Schelfhout V; De Potter CR; Brock P; Uyttebroeck A; Sciot R; Schuuring E; Versteeg R; Speleman F
Eur J Cancer; 1997 Oct; 33(12):1979-82. PubMed ID: 9516837
[TBL] [Abstract][Full Text] [Related]
36. Molecular cytogenetic characterization of two non-MYCN amplified neuroblastoma cell lines with complex t(11;17).
McConville CM; Dyer S; Rees SA; Luttikhuis ME; McMullan DJ; Vickers SJ; Ramani P; Redfern D; Morland BJ
Cancer Genet Cytogenet; 2001 Oct; 130(2):133-40. PubMed ID: 11675134
[TBL] [Abstract][Full Text] [Related]
37. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
[TBL] [Abstract][Full Text] [Related]
38. Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
Sanmartín E; Muñoz L; Piqueras M; Sirerol JA; Berlanga P; Cañete A; Castel V; Font de Mora J
Clin Cancer Res; 2017 Nov; 23(22):6875-6887. PubMed ID: 28830922
[No Abstract] [Full Text] [Related]
39. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
Gehring M; Berthold F; Edler L; Schwab M; Amler LC
Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]